Siblings Conference Papers/Meeting Abstract [4/6] Collection Statistics Item counts issued in 3 years:1(11.11%) Items With Fulltext:9(100.00%) Download counts of the item Download times greater than 0:9(100.00%) Download times greater than 100:9(100.00%) Total Bitstream Download Counts:4842(59.96%) Last Update: 2024-11-28 18:50 Top Upload Loading... Top Download Loading... Recent Submissions BPR3P0128, a non-nucleoside RNA-dep... Discovery of an orally efficacious ... Discovery of BPR1K871, a quinazolin... Homology modeling of DFG-in FMS-lik... Anaplastic lymphoma kinase (ALK) in... Ligand efficiency based approach fo... Small-molecule EGFR tyrosine kinase... 3D-QSAR-assisted drug design: Ident...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-9 of 9. (1 Page(s) Totally) 1  View [10|25|50] records per page

Date	Title	Relation
2024-04	BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir	Antimicrobial Agents and Chemotherapy. 2024 Apr 3;68(4):Article number e0095623
2021-06-16	Discovery of an orally efficacious MYC inhibitor for liver cancer using a GNMT-based high-throughput screening system and structure-activity relationship analysis	Journal of Medicinal Chemistry. 2021 Jun 16;64(13):8992-9009.
2016-12	Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation	Oncotarget. 2016 Dec;7(52):86239-86256.
2016-11-29	Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design	European Journal of Medicinal Chemistry. 2016 Nov 29;124:186-199.
2015-06-29	Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification	Scientific Reports. 2015 Jun 29;5:Article number 11702.
2014-10	Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer	Expert Opinion on Investigational Drugs. 2014 Oct;23(10):1333-1348.
2014-08	Ligand efficiency based approach for efficient virtual screening of compound libraries	European Journal of Medicinal Chemistry. 2014 Aug;83:226-235.
2014-07	Anaplastic lymphoma kinase (ALK) inhibitors: A review of design and discovery	MedChemComm. 2014 Jul;5(9):1266-1279.
2013-01	3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor	ChemMedChem. 2013 Jan;8(1):136-148.

Showing items 1-9 of 9. (1 Page(s) Totally) 1  View [10|25|50] records per page